A Simple Single-item Rating Scale to Measure Medication Adherence: Further Evidence for Convergent Validity

Overview

Journal J Int Assoc Physicians AIDS Care (Chic)

Publisher Sage Publications

Specialty Infectious Diseases

Date 2009 Dec 3

PMID 19952289

Citations 101

Authors

Seth C Kalichman

Christina M Amaral

Connie Swetzes

Michelle Jones

Rene Macy

Moira O Kalichman

Chauncey Cherry

Affiliations

Soon will be listed here.

Abstract

Background: Self-report measures of medication adherence are inexpensive and minimally intrusive. However, the validity of self-reported adherence is compromised by recall errors for missed doses and socially desirable responding.

Method: Examined the convergent validity of 2 self-report adherence measures administered by computerized interview: (a) recall of missed doses and (b) a single-item visual analogue rating scale (VAS). Adherence was also monitored using unannounced phone-based pill counts that served as an objective benchmark.

Results: The VAS obtained adherence estimates that paralleled unannounced pill counts (UPCs). In contrast, self-reported recall (SR-recall) of missed medications consistently overestimated adherence. Correlations with participant characteristics also suggested that the computer-administered VAS was less influenced by response biases than SR-recall of missed medication doses.

Conclusions: A single-item VAS offers an inexpensive and valid method of assessing medication adherence that may be useful in clinical as well as research settings.

Citing Articles

Suitability of Measures of Pharmacy-Based Medication Adherence for Routine Clinical Use Among Patients with Chronic Diseases: A Systematic Review.

Jannah W, Khoiry Q, Alfian S, Abdulah R Patient Prefer Adherence. 2025; 19:265-278.

PMID: 39901904 PMC: 11789522. DOI: 10.2147/PPA.S492461.

Cross-cultural adaptation of the simple Chinese version of the medication adherence reasons scale in patients undergoing adjuvant endocrine therapy for breast cancer.

Xu L, Li P, Hu Y, Xing W, Qiu J, Zhang X BMC Cancer. 2025; 25(1):41.

PMID: 39780104 PMC: 11707837. DOI: 10.1186/s12885-024-13382-4.

Examining the Accuracy of Self-Reported Antiretroviral Therapy Adherence Using a Visual Analog Scale Among Opioid-Dependent People Living with HIV.

Ssenyonjo J, Li X, Shrestha R, Copenhaver M AIDS Behav. 2024; 28(12):4046-4051.

PMID: 39500816 DOI: 10.1007/s10461-024-04526-5.

Supporting treatment adherence for resilience and thriving (START): protocol for a mHealth randomized controlled trial.

Davis-Ewart L, Atkins L, Ghanooni D, Diaz J, Chuku C, Balise R BMC Public Health. 2024; 24(1):2350.

PMID: 39210314 PMC: 11360769. DOI: 10.1186/s12889-024-19745-7.

Discrepancies between self-reported medication in adherence and indirect measurement adherence among patients undergoing antiretroviral therapy: a systematic review.

Liao R, Tang Z, Zhang N, Hu L, Chang Z, Ren J Infect Dis Poverty. 2024; 13(1):51.

PMID: 38970140 PMC: 11225374. DOI: 10.1186/s40249-024-01221-4.

References

Saunders J, Aasland O, Babor T, De la Fuente J, Grant M . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993; 88(6):791-804. DOI: 10.1111/j.1360-0443.1993.tb02093.x. View

Gill C, Sabin L, Hamer D, Keyi X, Jianbo Z, Li T . Importance of dose timing to achieving undetectable viral loads. AIDS Behav. 2009; 14(4):785-93. PMC: 3857692. DOI: 10.1007/s10461-009-9555-9. View

Oyugi J, Byakika-Tusiime J, Charlebois E, Kityo C, Mugerwa R, Mugyenyi P . Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004; 36(5):1100-2. DOI: 10.1097/00126334-200408150-00014. View

Chesney M, Ickovics J, Chambers D, Gifford A, Neidig J, Zwickl B . Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group.... AIDS Care. 2000; 12(3):255-66. DOI: 10.1080/09540120050042891. View

Garber M, Nau D, Erickson S, Aikens J, Lawrence J . The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004; 42(7):649-52. DOI: 10.1097/01.mlr.0000129496.05898.02. View

Giordano T, Guzman D, Clark R, Charlebois E, Bangsberg D . Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004; 5(2):74-9. DOI: 10.1310/JFXH-G3X2-EYM6-D6UG. View

Gifford A, Bormann J, Shively M, WRIGHT B, Richman D, Bozzette S . Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000; 23(5):386-95. DOI: 10.1097/00126334-200004150-00005. View

Catz S, Kelly J, Bogart L, Benotsch E, McAuliffe T . Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000; 19(2):124-33. View

Pearson C, Simoni J, Hoff P, Kurth A, Martin D . Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2006; 11(2):161-73. PMC: 5096443. DOI: 10.1007/s10461-006-9133-3. View

10.

Bangsberg D, Bronstone A, Chesney M, Hecht F . Computer-assisted self-interviewing (CASI) to improve provider assessment of adherence in routine clinical practice. J Acquir Immune Defic Syndr. 2003; 31 Suppl 3:S107-11. DOI: 10.1097/00126334-200212153-00004. View

11.

Kalichman S, Amaral C, Cherry C, Flanagan J, Pope H, Eaton L . Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008; 9(5):298-308. PMC: 2937191. DOI: 10.1310/hct0905-298. View

12.

Petersen M, Wang Y, van der Laan M, Guzman D, Riley E, Bangsberg D . Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007; 45(7):908-15. PMC: 2442040. DOI: 10.1086/521250. View

13.

Kalichman S, Cain D, Cherry C, Kalichman M, Pope H . Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDS. 2005; 19(12):833-9. DOI: 10.1089/apc.2005.19.833. View

14.

Kalichman S, Amaral C, Stearns H, White D, Flanagan J, Pope H . Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Intern Med. 2007; 22(7):1003-6. PMC: 2219717. DOI: 10.1007/s11606-007-0171-y. View

15.

Walsh J, DAlton M, Gazzard B . Adherence to combination antiretroviral therapy assessed by anonymous patient self-report. AIDS. 1998; 12(17):2361-3. View

16.

Gribble J, Miller H, Rogers S, Turner C . Interview Mode and Measurement of Sexual Behaviors: Methodological Issues. J Sex Res. 2012; 36(1):16-24. PMC: 3516293. DOI: 10.1080/00224499909551963. View

17.

Amico K, Fisher W, Cornman D, Shuper P, Redding C, Konkle-Parker D . Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr. 2006; 42(4):455-9. DOI: 10.1097/01.qai.0000225020.73760.c2. View

18.

Reynolds N, Sun J, Nagaraja H, Gifford A, Wu A, Chesney M . Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis. J Acquir Immune Defic Syndr. 2007; 46(4):402-9. DOI: 10.1097/qai.0b013e318158a44f. View

19.

Gribble J, Miller H, Cooley P, Catania J, Pollack L, Turner C . The impact of T-ACASI interviewing on reported drug use among men who have sex with men. Subst Use Misuse. 2000; 35(6-8):869-90. DOI: 10.3109/10826080009148425. View

20.

DeJesus E, Young B, Morales-Ramirez J, Sloan L, Ward D, Flaherty J . Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients. J Acquir Immune Defic Syndr. 2009; 51(2):163-74. DOI: 10.1097/QAI.0b013e3181a572cf. View